NCT02184416 2026-02-27
ADONIS
Pfizer
Completed
Clinical Trials
145 trialsNCT05858749 2026-02-27
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
Completed
NCT04501913 2025-12-05
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Completed
NCT05579847 2025-12-04
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT04941768 2025-11-28
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
NCT07181954 2025-09-19
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
First Affiliated Hospital of Fujian Medical University
Completed
NCT03841149 2025-09-15
VolUS3D
Assistance Publique - Hôpitaux de Paris
Completed
NCT07117786 2025-08-12
Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
First Affiliated Hospital of Fujian Medical University
Completed
NCT02940639 2025-07-11
Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy
Bristol-Myers Squibb
Completed
NCT04006405 2025-06-15
AUR87A
Elypta
Completed
NCT04802824 2025-05-02
Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
Imperial College London
Completed
NCT05976607 2025-04-17
Clinical Study of 18F -FAPI-RGD in Renal Tumor
Sichuan Provincial People's Hospital
Completed
NCT04804813 2025-04-11
Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
Takeda
Completed
NCT06883565 2025-03-19
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
Fudan University
Completed
NCT06876584 2025-03-14
The CT-based Deep Learning Model Predicts Complications in Partial Nephrectomy
Fudan University
Completed
NCT03891485 2025-03-11
REVOLUTION
National Cancer Institute, Naples
Completed
NCT06829888 2025-02-17
CRYO-BO-2021
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Completed
NCT04043975 2025-02-14
A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan
Bristol-Myers Squibb
Completed
NCT06778538 2025-01-16
HPGD-ccRCC
Lanzhou University Second Hospital
Completed
NCT06761742 2025-01-07
Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests
RenJi Hospital
Completed
NCT06656039 2024-10-24
A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma
RenJi Hospital
Completed
NCT04883827 2024-10-22
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
Vanderbilt-Ingram Cancer Center
Completed
NCT04005183 2024-10-10
REMEDY
University Health Network, Toronto
Completed
NCT06607809 2024-10-08
IMNR
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Completed
NCT05363072 2024-10-01
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Pfizer
Completed
NCT01210482 2024-09-25
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer
Completed
NCT04375150 2024-09-19
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Pfizer
Completed
NCT06559046 2024-08-20
A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study
Zhejiang University
Completed
NCT05112627 2024-08-09
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
Mayo Clinic
Completed
NCT05745142 2024-08-05
A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.
Pfizer
Completed
NCT00026663 2024-07-01
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
National Institutes of Health Clinical Center (CC)
Completed
NCT01002937 2024-06-18
Novel Prognostic Markers in Renal Cancer
Royal Marsden NHS Foundation Trust
Completed
NCT03776123 2024-05-29
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
Ipsen
Completed
NCT00970970 2024-05-06
VHLimage
University Medical Center Groningen
Completed
NCT01028638 2024-05-06
Everolimage
University Medical Center Groningen
Completed
NCT01398306 2024-05-06
BANN
University Medical Center Groningen
Completed
NCT06317207 2024-03-19
LiangAH
The First Affiliated Hospital of Anhui Medical University
Completed
NCT05012865 2023-12-06
Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)
Pfizer
Completed
NCT06111560 2023-11-01
Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma
Sun Yat-sen University
Completed
NCT00617799 2023-10-10
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
Completed
NCT00716625 2023-05-03
Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)
Pfizer
Completed
NCT04175262 2023-05-03
Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments
Pfizer
Completed
NCT02850809 2023-04-28
RF-REIN
University Hospital, Bordeaux
Completed
NCT04076787 2023-04-06
Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib
Pfizer
Completed
NCT02732665 2023-04-05
Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma
Chalmers University of Technology
Completed
NCT02732652 2023-03-22
Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma
Chalmers University of Technology
Completed
NCT02776644 2023-03-16
Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan
Pfizer
Completed
NCT04402749 2023-03-16
The Incidence of Pulmonary Embolism During Nephrectomy
Mahidol University
Completed
NCT05729763 2023-02-15
Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study
San Luigi Gonzaga Hospital
Completed
NCT04072224 2023-01-26
Ablation
Centre Hospitalier Universitaire de NÄ«mes
Completed